Related Experiment Video
Updated: Feb 21, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming
Laura C Armstrong1, Grant Westlake1, John P Snow1
1Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA.
Abstract:
Tuberous sclerosis complex (TSC) is a pediatric disorder of dysregulated growth and differentiation caused by loss of function mutations in either the TSC1 or TSC2 genes, which regulate mTOR kinase activity. To study aberrations of early development in TSC, we generated induced pluripotent stem cells using dermal fibroblasts obtained from patients with TSC. During validation, we found that stem cells generated from TSC patients had a very high rate of integration of the reprogramming plasmid containing a shRNA against TP53. We also found that loss of one allele of TSC2 in human fibroblasts is sufficient to increase p53 levels and impair stem cell reprogramming. Increased p53 was also observed in TSC2 heterozygous and homozygous mutant human stem cells, suggesting that the interactions between TSC2 and p53 are consistent across cell types and gene dosage. These results support important contributions of TSC2 heterozygous and homozygous mutant cells to the pathogenesis of TSC and the important role of p53 during reprogramming.
Insights
Tuberous sclerosis complex (TSC) involves gene mutations affecting cell growth. This study found that TSC2 gene variations increase p53 levels, impacting stem cell reprogramming and TSC development.
Area of Science:
- Genetics
- Developmental Biology
- Cell Biology
Background:
- Tuberous sclerosis complex (TSC) is a pediatric genetic disorder characterized by abnormal cell growth and differentiation.
- TSC results from loss-of-function mutations in TSC1 or TSC2 genes, which are critical regulators of mTOR kinase activity.
- Understanding early developmental aberrations in TSC is crucial for therapeutic strategies.
Purpose of the Study:
- To investigate the role of TSC2 and p53 interactions in the pathogenesis of Tuberous Sclerosis Complex.
- To analyze stem cell reprogramming efficiency in TSC patient-derived cells.
- To determine the impact of TSC2 gene dosage on p53 levels and cellular reprogramming.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs) from dermal fibroblasts of TSC patients.
- Assessment of reprogramming plasmid integration rates in TSC-derived stem cells.
- Quantification of p53 protein levels in human fibroblasts and stem cells with varying TSC2 genotypes (heterozygous and homozygous mutants).
Main Results:
- Stem cells derived from TSC patients exhibited a high rate of reprogramming plasmid integration, including shRNA targeting TP53.
- Loss of a single TSC2 allele in human fibroblasts was sufficient to elevate p53 levels and hinder stem cell reprogramming.
- Elevated p53 levels were consistently observed in TSC2 heterozygous and homozygous mutant human stem cells, indicating conserved TSC2-p53 interactions.
Conclusions:
- TSC2 heterozygous and homozygous mutant cells significantly contribute to the pathogenesis of Tuberous Sclerosis Complex.
- The p53 pathway plays a critical role during the stem cell reprogramming process in the context of TSC.
- The interaction between TSC2 and p53 is consistent across different cell types and gene dosage, highlighting its importance in TSC.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Somatic to iPS Cell Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

